Skip to content
Home/Companies/Biotech/Advanced Cell Diagnostics

Advanced Cell Diagnostics

Biotech·US·Active
Entry
–
Hold
–
Status
Active

Who owns Advanced Cell Diagnostics?

Advanced Cell Diagnostics is currently owned by Summit Partners.

Hand-verified · updated 2026-04-21

Summit Partners
Investor
Summit Partners
Fund attribution unclassified.

Key facts

HQUSA
SectorBiotech

More from Summit Partners Portfolio

Other portfolio companies in the same fund.

3 Day Blinds
3 Day Blinds
Active
ConsumerUS
A+ Network
Active
TMTUS
A10 Networks
A10 Networks
Active
TMTUS
Ability Network
Active
SaaSUS
Abode Healthcare
Active
HealthcareUS
Acacia Communications
Acacia Communications
Active
TMTUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Advanced Cell Diagnostics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Advanced Cell Diagnostics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Advanced Cell Diagnostics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue